Navigation Links
The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments
Date:4/30/2008

A Significant Accomplishment for the PLSG and the Life Sciences Industry in

Western Pennsylvania

PITTSBURGH, April 30 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to the region's life sciences enterprises, announced that the PLSG has reached a significant milestone with over $10 million in direct company investments. PLSG's investment of $235,000 in Lipella Pharmaceuticals for the support of pre-clinical testing and manufacturing of their therapy for the treatment of bladder dysfunction pushed them over the $10 million mark.

Since forming in 2002, the PLSG has committed $10.1 million into its Investment Portfolio of 48 life sciences companies which has leveraged over $300 million in additional capital for these emerging businesses. The PLSG continues to propel the growth of western Pennsylvania's life sciences economy by investing in the commercialization of promising life sciences technologies.

"Hitting the $10 million mark is a significant accomplishment for the PLSG and the life sciences industry in our region," said John W. Manzetti, PLSG president & CEO. "We are making a significant impact on life sciences commercialization in western Pennsylvania: new company formation is up, new wealth is being created, and new products -- with important, positive ramifications for human health and quality of life -- are beginning to reach the marketplace."

As western Pennsylvania's only organization solely focused on the biosciences industry, the PLSG has brought the required energy, domain-specific expertise and efficiency to the task of establishing a critical mass of life sciences awareness, research, development and commercialization in the region. The task moving forward is to expand those efforts and increase the successful commercialization of viable life sciences ventures.

Mr. Manzetti continued, "in addition to our direct investments into companies, we are working with over 250 companies to guide them through the difficult challenges they face in the early stages of company development. We also fuel the expansion of life sciences companies in the growth and maturity stages by supporting new product and market developments and through our Venture Capital Partnerships program to guide investment firms or individual investors to emerging life sciences opportunities in western Pennsylvania."

Mr. Manzetti concluded, "the PLSG team is committed to serving our clients by providing executive talent, business and domain experience and capital to bring our region's concepts to the market. Our combined domain and business experience is unmatched, and we are bringing more technologies into our "Concept to Commercialization(TM)" pipeline each and every day. Our work is attracting talent, technology and capital to the region to make the mission a success."

Summary of PLSG Accomplishments to Date:

-- The PLSG has invested $10.1 million directly into 48 companies to help

leverage over $300 million in additional capital.

-- The PLSG has assisted over 250 clients/companies through its Executive-

in-Residence program.

-- The PLSG has invested $15.2 million in venture capital funds to help

leverage an additional $110 million in total funding.

-- The PLSG's SBIR Advance program has assisted nearly 100 companies with

their federal grant strategies. To date, these companies have received

over $13 million in federal grant funding.

-- The PLSG has provided 27 early stage companies and venture capital and

life sciences organizations with office and laboratory space in our

incubator.

-- The PLSG has assisted 10 life sciences companies with relocating to our

region and is working with other companies who would like to establish

operations in southwestern Pennsylvania.

-- The PLSG has leveraged $2.4 million in federal grant money to help

provide core and customized life sciences specific workforce training

to over 5,000 trainees since September, 2005.

-- The PLSG has helped create 5,000 jobs directly/indirectly including

university faculty and facilities. (300+ jobs created in invested

companies and 1,000+ jobs in PLSG active companies/clients)

-- 25 executives have participated in the PLSG EIR program: 7 are

currently active at PLSG and 16 former EIRs remain in the region.

-- The regional life sciences company formation rate has increased from 2-

3 per year to 15-20 new companies per year.

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The PLSG invests in and supports the growth of biosciences companies in western Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the region. http://www.plsg.com


'/>"/>
SOURCE The Pittsburgh Life Sciences Greenhouse
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
2. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
3. The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors
4. The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio
5. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
6. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
7. Robert W. Lee, Ph.D. Joins Particle Sciences as Vice President of Pharmaceutical Development
8. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
9. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2008 Financial Results
10. Caliper Life Sciences Reports West Coast Consolidation of Operations
11. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... Patient Monitoring ... with Wi-Fi connectivity to reduce the amount of wiring in a healthcare facility ... compact mobile devices including infusion pumps, heart and hypertension monitoring, glucose monitoring, and ...
(Date:5/23/2017)... ... May 23, 2017 , ... Firmex ... solution that makes it easy for organizations to send and gather large files ... FTP software or email file size limitations. , Using the same market-tested ...
(Date:5/23/2017)... , ... May 23, 2017 ... ... an unlimited source of human cardiovascular cells for research and the development ... makes it possible to generate large numbers of cardiomyocytes (hPSC-CMs). Due to ...
(Date:5/23/2017)... ... May 22, 2017 , ... NetDimensions has been ... Aragon Research Globe™ for Corporate Learning, 2017. , Aragon Research defines Leaders as ... and effectively perform against those strategies. NetDimensions’ ranking as a Leader due to ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... prestigious international IAIR Award for the most innovative high security ePassport and ... ... Maldives Immigration Controller General, Mr. Mohamed ... the right) have received the IAIR award for the "Most innovative high ...
Breaking Biology News(10 mins):